Regarding drug pricing transparency
Enacted | Last Action: Jun 21, 2021
An Act To Increase Prescription Drug Pricing Transparency
Regarding drug pricing transparency
ACTPUB , Chapter 305
Signed by the Governor
PASSED TO BE ENACTED. Sent for concurrence. ORDERED SENT FORTHWITH.
PASSED TO BE ENACTED, in concurrence.
Reports READ.On motion of Representative TEPLER of Topsham, the Majority Ought to Pass as Amended Report was ACCEPTED.The Bill was READ ONCE.Committee Amendment "A" (S-255) was READ and ADOPTED.Under suspension of the rules, the Bill was given its SECOND READING without REFERENCE to the Committee on Bills in the Second Reading.The Bill was PASSED TO BE ENGROSSED as Amended by Committee Amendment "A" (S-255).In concurrence. ORDERED SENT FORTHWITH.
Taken from the table by the President On motion by Senator SANBORN of Cumberland The Majority Ought to Pass As Amended Report ACCEPTED Roll Call Ordered Roll Call Number 375 Yeas 33 - Nays 1 - Excused 1 - Absent 0 READ ONCE Committee Amendment "A" (S-255) READ and ADOPTED Under suspension of the Rules, READ A SECOND TIME and PASSED TO BE ENGROSSED AS AMENDED by Committee Amendment "A" (S-255) Sent down for concurrence
CARRIED OVER, in the same posture, to a subsequent special or regular session of the 130th Legislature, pursuant to Joint Order SP 435.
Received by the Secretary of the Senate on March 2, 2021 and REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES pursuant to Joint Rule 308.2